Trial intelligence / Profile preview

OPT-BP: Tight vs Usual Blood Pressure Control Postpartum

NCT06069102Phase 4Completed

Start
Nov 2023
Primary completion
May 2025
Countries
1
01

Overview

Phase 4, randomised, open-label trial in hypertensive disorder of pregnancy (HDP) (2 arms). Primary endpoint: Percent of Participants Eligible, Enrolled and Retained at 6 months. Started Nov 2023; status: completed.

02

Conditions

hypertensive disorder of pregnancy (HDP)

Beyond the preview

Go deeper on NCT06069102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06069102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call